BioNTech SE logo

BNTX - BioNTech SE News Story

$122.14 7.7  6.7%

Last Trade - 09/04/21

Large Cap
Market Cap £21.52bn
Enterprise Value £20.56bn
Revenue £418.6m
Position in Universe 430th / 6827

Hungarian, Czech premiers to meet Israeli PM on pandemic strategy

Tue 9th March, 2021 8:41am
BUDAPEST, March 9 (Reuters) - The Hungarian and Czech prime
ministers will meet Israeli Prime Minister Benjamin Netanyahu on
Thursday to discuss policies to fight COVID-19 as a third wave
of the coronavirus pandemic sweeps central Europe.
    "The main topic of the meeting will be the effort to curb
the pandemic," Hungarian Prime Minister Viktor Orban's press
chief said in a statement.
    Netanyahu, who has said 90% of eligible Israelis have either
received at least one dose of the Pfizer/BioNTech vaccine or
recovered from the virus, has made Israel's vaccination
programme a showcase of his campaign for re-eection on March 23.
    Last week Israel, Austria and Denmark said they would set up
a joint research and development fund, and possibly production
facilities for COVID-19 vaccines, to ensure they had long-term
supplies for booster shots or to contend with virus mutations.
    Hungary imposed tough new lockdown measures on Monday to
curb a rise in COVID-19 infections and has accelerated its
vaccination campaign. 
    Orban's government has closed all schools and most shops in
his country of 10 million.
    The Czech Republic, a country of 10.7 million, has been hit
hard by the pandemic in recent weeks, with the number of
COVID-19 patients in serious condition at new highs and some
hospitals nearing capacity. Prague has asked Germany, Poland and
Switzerland to take in some patients.
   The Czech government has sought to turn the tide with a
strict lockdown restricting travel around the country and has
boosted testing at industrial companies that have been untouched
by restrictions.

 (Reporting by Krisztina Than, additional reporting by Jason
Hovet in Prague, Editing by Timothy Heritage)
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.